[Treatment of membranous lupus nephritis].
Nakano
M
M
Department of Medicine (II), Niigata University School of Medicine.
D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D004176:Dipyridamole / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008181:Lupus Nephritis / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000627:therapeutic use
D000806:Angiotensin-Converting Enzyme Inhibitors; D007166:Immunosuppressive Agents; D014665:Vasodilator Agents; D004176:Dipyridamole